Related Experiment Videos
Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological
W Bourguet1, P Germain, H Gronemeyer
1Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/ULP, BP 163, 67404 Illkirch Cedex, C.U. de Strasbourg, France. bourguet@igbmc.u-strasbg.fr
Trends in Pharmacological Sciences
|October 26, 2000
Summary
Nuclear receptors are crucial transcription factors. Understanding their ligand-binding domains reveals mechanisms of activation and informs drug design for various conditions.
Area of Science:
- Molecular biology
- Structural biology
- Pharmacology
Background:
- Nuclear receptors are ligand-inducible transcription factors regulating diverse physiological processes.
- Crystal structures of nuclear receptor ligand-binding domains offer detailed mechanistic insights.
- Understanding receptor activation and signal transduction is key to therapeutic interventions.
Purpose of the Study:
- To present a comprehensive mechanistic view of nuclear receptor agonist and antagonist action.
- To describe the novel class of partial agonists-antagonists.
- To discuss challenges and perspectives in nuclear receptor-based drug design.
Main Methods:
- Structural analysis of nuclear receptor ligand-binding domains.
- Mechanistic interpretation of ligand-induced receptor activation.
- Review of existing literature and emerging concepts in nuclear receptor pharmacology.
Main Results:
- Detailed insights into intra- and intermolecular mechanisms of receptor activation.
- Elucidation of agonist and antagonist actions at the molecular level.
- Introduction of partial agonists-antagonists as a distinct functional class.
Conclusions:
- Structural data provides a mechanistic basis for understanding nuclear receptor function.
- Agonist, antagonist, and partial agonist-antagonist activities are mechanistically defined.
- Novel perspectives and challenges exist for developing targeted nuclear receptor therapies.